Featured
Last news
BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise
KUALA LUMPUR, MY / ACCESS Newswire / November 13, 2025 / BMS Holdings Berhad ("BMS Holdings" or the "Company"), a deep-rooted Malaysian retailer and distributor specialising in tiles, stone surfaces, bathware and kitchenware, successfully launched its prospectus today in conjunction with its upcoming Initial Public Offering ("IPO") and listing on the ACE Market of Bursa Malaysia Securities Berhad ("Bursa Securities").
HPB and Coperion Partner on Next-Generation Slurry Production
New to The Street will be covering across all media.
Cosmoprof North America Miami Returns for Its Third Edition, January 27-29, 2026: Staying Ahead in Beauty, Innovation, and Industry Insights
More than 800 brands and suppliers unite in Miami to showcase the future of beauty across skin care, makeup, fragrance, hair, nails, and the entire supply chain.
Premiere Columbus 2025 Delivers Education, Inspiration, and New Experiences for Midwest Beauty Pros
COLUMBUS, OH / ACCESS Newswire / November 13, 2025 / Premiere Show Group, the nation's leading network of beauty industry events and professional education, successfully concluded Premiere Columbus 2025, energizing the Midwest beauty community with two days of world-class education, high-energy competition, and innovative attendee experiences. Held September 14-15 at the Greater Columbus Convention Center, the show brought together 10,000 visits of licensed professionals and students alongside 129 exhibiting brands for a weekend of skill-building, discovery, and networking.
Trifecta Partners with Prado to Make Healthy Meal Delivery Eligible for HSA/FSA Use
Making Medically Approved Meals More Accessible Nationwide for People Managing Chronic Conditions
Mosaic Completes Offering of an Aggregate $900 Million of 3-Year and 5-Year Senior Notes
TAMPA, FL / ACCESS Newswire / November 13, 2025 / The Mosaic Company (NYSE:MOS) today announced that it has completed an underwritten public offering (the "Offering") of $500 million aggregate principal amount of 4.350 percent senior notes due January 2029 and $400 million aggregate principal amount of 4.600 percent senior notes due November 2030 (collectively, the "Notes").
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2025.
Newsmax Announces Third Quarter 2025 Financial Results
Company Reports Revenues of $45.3 million, a 4.0% Year-Over-Year Increase, Outpacing Election-Year ComparisonBroadcast Revenues Increase to $36.6 Million, a 10.1% Increase Year-Over-YearNewsmax Remains the Fourth Highest-Rated Cable News Channel With Over 28 Million Quarterly Viewers
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
WINNIPEG, MB / ACCESS Newswire / November 13, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present Financial Results for the quarter ended September 30, 2025 via conference call on November 20, 2025 at 8:30 am Eastern Time. The Financials for the quarter ended September 30, 2025 will be filed after market close on November 19, 2025.
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
Total net revenue of $13.9 millionNet income of $2.0 million, or $0.21 net income per share basicAdjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments$32.6 million cash balance at September 30, 2025Company remains on track to launch EXXUA™ (gepirone) extended-release tablets ("EXXUA") in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") marketCompany to host conference call and webcast today, November 13, 2025, at 4:30 p.m. Eastern time
Electronic Caregiver Announces Breakthrough Results from National Medicare Test of Addison Care(R), Demonstrating Unprecedented Patient Engagement, High Reliability, and Scalability for Nationwide Rollout
LAS CRUCES, NEW MEXICO / ACCESS Newswire / November 13, 2025 / Electronic Caregiver, Inc. today announced outstanding clinical performance from a multi-state Medicare service test of Addison Care®, the industry's first 3D Virtual Caregiver designed to support chronically ill older adults at home with 24/7 intelligent care, guidance, and daily engagement.
Tenon(R) Medical Reports Third Quarter 2025 Financial Results
~ Record revenue of $1.2 million, a 32% year-over-year increase, reflecting record volume in Catamaran® SI Joint Fusion System procedures and the addition of SImmetry® SI Joint Fusion Product Sales ~~ SImmetry®+ alpha launch in Q4 2025 advances strategic portfolio ~~ Foundation set for sustained growth through portfolio diversification, commercial expansion and operational alignment ~~ Subsequent to quarter end the Company announced the pricing of a PIPE financing with an industry supportive investor cohort raising total gross proceeds of $2.85 million ~
US jury: Boeing owes $28 mn to family of Ethiopian Airlines crash victim
A US jury in the first civil trial over a fatal Boeing 737 MAX crash determined Wednesday that the aircraft manufacturing giant owes $28.45 million to the family of a newly-wed Indian victim.
Back on track: Belgian-Dutch firm rescues Berlin to Paris sleeper train
Railway fans devastated by the scrapping of a much-heralded Berlin to Paris night train can breathe again after a Belgian-Dutch cooperative stepped in Wednesday to keep the service going.
Algeria pardons writer Boualem Sansal
Algeria has pardoned French-Algerian writer Boualem Sansal after a request from Germany, to where he will be transferred for medical treatment after a year in detention, it was announced Wednesday.
Pope Leo reels off four favourite films
Pope Leo XIV has revealed his four favourite films ahead of a special audience with Hollywood celebrities and Oscar-winning directors at the Vatican.
Pakistan tightens Islamabad security after suicide blast
Residents in the Pakistani capital Islamabad were facing tightened security checks on Wednesday in the wake of a suicide bombing that left top officials vowing to halt the rise in deadly attacks.
Corruption scandal, court battles pose test for Zelensky
A major corruption scandal and mounting accusations that the Ukrainian presidency is using the judiciary to intimidate and silence critics has rocked Kyiv, presenting a significant test for Volodymyr Zelensky almost four years into the Russian invasion.
DR Congo ex-rebel leader Lumbala's war crimes trial opens in Paris
Former Congolese rebel leader Roger Lumbala goes on trial in Paris Wednesday over atrocities committed in the Democratic Republic of Congo's bloody eastern conflict more than two decades ago.
Cambodia's Prince Group denies link to scams after asset seizures
A Cambodian conglomerate whose founder has had more than $15 billion of allegedly ill-gotten assets seized said it "categorically rejects" claims he amassed his fortune running an internet scam empire.
Ousted Gabon leader's wife and son sentenced to 20 years for graft
A Gabon court on Wednesday sentenced the former first lady and son of the oil-rich country's deposed leader Ali Bongo to 20 years in prison following a two-day graft trial.
Bangladesh's liquor industry a surprising success
Syrupy aromas drift across the guarded compound of Bangladesh's only licensed distillery, a state-owned producer posting record profits in the Muslim-majority nation, where Islamists are staging a political comeback.
CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth
With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market.
Wellgistics Health Launches EinsteinRx as the Premier AI Prescription Management Hub Solution to Integrate Physical and Technology Healthcare Infrastructure
Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and manufacturersIntegration of technology and physical infrastructure positions Wellgistics with the "Pharmacy IT Railroad" to execute on PharmacyChain™ smart contracts for optimized healthcare delivery in the $634 billion United States prescription drug market
Jerash Holdings Reports Fiscal 2026 Second Quarter Financial Results
FAIRFIELD, NEW JERSEY / ACCESS Newswire / November 12, 2025 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, today announced financial results for its fiscal 2026 second quarter ended September 30, 2025.
Dalet Named a Major Player in the 2025 IDC MarketScape for Worldwide Media Production, Distribution, and Monetization Integrated Cloud Solutions
NEW YORK, US / ACCESS Newswire / November 12, 2025 / Dalet, a leading provider of cloud-native, end-to-end media workflow solutions, today announced that it has been recognized as a Major Player in the IDC MarketScape: Worldwide Media Production, Distribution, and Monetization Integrated Cloud Solutions 2025 Vendor Assessment*. The report evaluates technology vendors helping media organizations streamline production, distribution, and monetization through unified cloud platforms.
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populationsFDA clearance of IND application triggered a US$ 5 m milestone payment to Evotec
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and iron-modulating activity - key to its broader epigenetic mechanism of action.
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
KELOWNA, BC / ACCESS Newswire / November 12, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this update on the Material Transfer Agreement ("MTA") originally entered into on September 4, 2024 with a pharmaceutical company ("PharmaCO") to evaluate Lexaria's DehydraTECHTM technology in a pre-clinical setting.
The Dixie Group Reports Net Loss For The Third Quarter Of 2025
DALTON, GA / ACCESS Newswire / November 12, 2025 / The Dixie Group, Inc. (OTCQB:DXYN) today reported financial results for the quarter ended September 27, 2025.
Dolphin Clients Earn 35 Nominations for the 2026 GRAMMY Awards
Shore Fire Clients Alison Krauss & Union Station, Anoushka Shankar, Arturo O'Farrill & The Afro Latin Jazz Orchestra, Bon Iver, Margo Price, PJ Morton, Samara Joy, Tasha Cobbs Leonard, Tobias Jesso Jr. and 42West Client Andrew Watt All Receive Multiple NominationsAdditional Nods Include Shore Fire Clients Bilal, Bruce Springsteen, Deborah Silver & The Count Basie Orchestra, Grace Potter, Jacob Collier, Joni Mitchell (Rhino Entertainment), Rhiannon Giddens, Samantha Fish, TajMo (Taj Mahal & Keb' Mo'), Terri Lyne Carrington and Trombone Shorty
Federal HEMP Crackdown & Cannabis Court Rulings Confirm MMJ's Pharmaceutical Vision
As Congress and the courts reaffirm federal supremacy in cannabis-hemp regulation, MMJ International Holdings stands with a DEA licensed lab, two accepted FDA Investigational new drug applications, and a completed THC-CBD soft gelatin medicine-proving that true compliance, not state loopholes, defines the future of cannabis medicine.